The acceptance of the BBI-940 IND enables Boundless to advance the program into a first-in-human clinical trial for patients with metastatic breast cancer, KOMODO-1 (Kinesin Oral Molecular Degrader ...

A group of investors from across Kansas plans to build a 45-hole golf resort on land where a previous course opened and ...

Orion Pharma announces the initiation of TEADES Phase 2 trial of ODM-212 in Malignant Pleural Mesothelioma (MPM) and Epithelioid Hemangioendothelioma (EHE) ...

An imposing South Jersey mansion originally listed for sale three years ago is back on the market with a drastic reduction ...

The Kwanobuhle Initiation Task Team, made up of traditional leaders, health officials, police, religious leaders, and taxi industry players, visited hotspot areas.